Assignee profile:

Neuralab Limited

City:

Flatts

Country:

Bermuda

Published Applications:

13

Last publication date:

2007-02-20

Patent Grants:

5

Last grant date:

2007-02-20

Top Inventors for applications by Neuralab Limited

These are the the leading inventors for applications assigned to Neuralab Limited:

Recent patent applications by Neuralab Limited

Neuralab Limited based in Flatts, BM has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2007-02-20 ✅ Patent 7,179,892 granted on 2007-02-20
US10388389
-

Humanized antibodies that recognize beta amyloid peptide

#2 | 2005-11-17
US20050255122A1
Chemistry; metallurgy

Prevention and treatment of amyloidogenic disease

#3 | 2005-11-10
US20050249727A1
Chemistry; metallurgy

Prevention and treatment of amyloidogenic disease

#4 | 2005-09-01
US20050191292A1
Chemistry; metallurgy

Prevention and treatment of amyloidogenic disease

#5 | 2005-07-28
US20050163788A1
Chemistry; metallurgy

Prevention and treatment of amyloidogenic disease

#6 | 2005-07-21
US20050158304A1
Human necessities

Prevention and treatment of amyloidogenic disease

#7 | 2005-06-30
US20050142132A1
Chemistry; metallurgy

Prevention and treatment of amyloidogenic disease

#8 | 2005-03-17
US20050059591A1
Chemistry; metallurgy

Prevention and treatment of amyloidogenic disease

#9 | 2005-03-10 ✅ Patent 6,962,707 granted on 2005-11-08
US20050053614A1
Chemistry; metallurgy

Prevention and treatment of amyloidogenic disease

#10 | 2005-03-03
US20050048049A1
Chemistry; metallurgy

Prevention and treatment of amyloidogenic disease

#11 | 2005-02-17 ✅ Patent 6,946,135 granted on 2005-09-20
US20050037026A1
Chemistry; metallurgy

Prevention and treatment of amyloidogenic disease

#12 | 2005-01-27 ✅ Patent 6,972,127 granted on 2005-12-06
US20050019343A1
Chemistry; metallurgy

Prevention and treatment of amyloidogenic disease

#13 | 2005-01-27 ✅ Patent 8,034,339 granted on 2011-10-11
US20050019330A1
Chemistry; metallurgy

Prevention and treatment of amyloidogenic disease

AssigneeID:

298430 ⎘